logo

For the Inventor, By the Inventor

Suita, Japan

Kimiaki Hayashi

This inventor holds 7 USPTO granted patents, plus 1 CIPO patent. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1980-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kimiaki Hayashi. Retrieved from https://idiyas.com/inventor/kimiaki-hayashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 36(Granted Patents)


Location History:

  • Nara, JP (1980)
  • Suita, JP (1981 - 1993)

Company Filing History:

goldMedal7 out of 324 
 
Tanabe Seiyaku Company, Limited
 patents

Years Active: 1980-1993

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 5202312 - Imidazole-containing peptides having immunomodulatory activity (1993-04-13),
2. 5013845 - Process for preparing optically active 2-oxoimidazolidine derivatives (1991-05-07),
3. 4946862 - Thiophene derivative and process for preparing the same (1990-08-07),
4. 4857543 - Thiophene derivative and process for preparing the same (1989-08-15),
5. 4508727 - Antihypertensive 2-oxo-imidazolidine derivatives (1985-04-02),
6. 4256751 - Tetrahydroisoquinoline derivatives (1981-03-17),
7. 4228183 - Novel phenethylamine derivatives and processes for preparing same (1980-10-14),

Title: Kimiaki Hayashi: Innovator in Immunomodulatory Peptides

Introduction

Kimiaki Hayashi is a prominent inventor based in Suita, Japan. He has made significant contributions to the field of immunomodulatory peptides, holding a total of 7 patents. His work focuses on developing compounds that can aid in the treatment of various autoimmune diseases.

Latest Patents

One of Hayashi's latest patents involves imidazole-containing peptides that exhibit immunomodulatory activity. This patent describes a specific formula where R¹ is a branched alkyl group, and R² and R⁴ can be hydrogen or lower alkyl groups. The compound is designed to be useful in treating autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. Another notable patent details a process for preparing optically active 2-oxoimidazolidine derivatives, which are essential in pharmaceutical applications.

Career Highlights

Kimiaki Hayashi is currently associated with Tanabe Seiyaku Company, Limited, where he continues to innovate in the field of pharmaceuticals. His research has led to advancements that have the potential to improve the quality of life for patients suffering from autoimmune conditions.

Collaborations

Hayashi has collaborated with notable colleagues, including Jyoji Kato and Naoto Yoneda, to further his research and development efforts. Their combined expertise has contributed to the success of various projects within the company.

Conclusion

Kimiaki Hayashi's work in immunomodulatory peptides showcases his dedication to advancing medical science. His patents reflect a commitment to addressing critical health issues through innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…